- Editor's PickSeana Smith•2 days ago
Pfizer is buying Medivation for $14 billion. Medivation’s portfolio includes Xtandi, a treatment for prostate cancer that generates about $2 billion in worldwide annual sales. Valeant Pharmaceuticals (VRX) — Zoetis (ZTS) Chief Financial Officer Paul Herendeen has stepped down to become executive vice president of finance at Valeant and will take over the role of CFO from Robert Rosiello effective immediately.
- Investor's Business Daily•11 hours ago
The fiber optic installer posted its biggest sales gain in nearly three years, but its EPS outlook missed, and it lowered its outlook for a new business unit.
- Associated Press•12 hours ago
___ US new-home sales climb to best level since late 2007 Americans stepped up their purchases of new homes in July to the fastest pace in nearly nine years, the latest sign that low mortgage rates and ...
AT&T, Inc. (T)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||40.74 x 100|
|Ask||41.46 x 300|
|Day's Range||40.78 - 41.03|
|52wk Range||31.85 - 43.89|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||17.62|
|Avg Vol (3m)||20,973,976|
|Dividend & Yield||1.92 (4.69%)|